Cancer

Category debug info: client: {"assets":{},"datasets":{},"live":{},"projects":{},"users":{},"observable":{"assets":{},"datasets":{},"live":{},"projects":{},"users":{}}}
Now: 1770747765225
Cache Key: cqdDataBySlug:cancer
fetchCache[cqdDataBySlug:cancer].expirationTime: 1770747764395
fetchCache[cqdDataBySlug:cancer]. seconds remaining: -0.83
All fetchCache expiration times:
-- Key: cqdNotFoundPage, seconds remaining: -830
-- Key: cqdDataBySlug:cancer, seconds remaining: -830
-- Key: cqdPostsByCategory:cqd-migrated-category-2522,44,10, seconds remaining: -797
-- Key: cqdDataBySlug:hairy-cell-leukemia-complicated-by-severe-covid-19-a-case-study, seconds remaining: 987
-- Key: cqdDataBySlug:urology-nephrology, seconds remaining: 5497
-- Key: cqdPostsByCategory:cqd-migrated-category-2524,54,10, seconds remaining: 5530
-- Key: cqdPostsByCategory:cqd-migrated-category-2522,63,10, seconds remaining: 4140
-- Key: cqdDataBySlug:case-study-a-rare-presentation-of-lupus-nephritis, seconds remaining: 5945
-- Key: cqdDataBySlug:technology-innovation, seconds remaining: 6407
-- Key: cqdPostsByCategory:cqd-migrated-category-2590,4,10, seconds remaining: 7324
conditions:
-- true,
-- true,
-- true,
-- false
-- false
Cache miss for key cqdDataBySlug:cancer - retrieving from Sanity
CCCache.dataFetchCount: 2208
Cache cleanup seconds remaining: 20987

Enasidenib Effective Treatment for Refractory Acute Myeloid Leukemia

Soft-Tissue Sarcomas: Consider Radiation First, Surgery Second

Circulating Cell-Free Genome Atlas Study Aims to Detect Cancer Before Symptoms Occur

Non-Cytotoxic Epigenetic Therapy for p53-Mutant/p16-Deleted Solid and Liquid Cancers

Study Warns Against De-Intensifying Treatment for Certain Oropharyngeal Cancer Patients

The Basics of High Reliability

Time to Treat is Increasing, Associated with Worsened Survival

Study Suggests Some Small Cell Lung Cancer Patients Benefit from Immune Checkpoint Inhibitor

Trial Finds Maximum Tolerable Dose for Combination Therapy for Metastatic Renal Cell Carcinoma Patients

Maximum Tolerable Doses for Adding Cell Checkpoint Inhibitor to Standard of Care for Glioblastoma Patients